PepGen
www.pepgen.comDriven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.
Read more
Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.
Read more
Country
State
Massachusetts
City (Headquarters)
Newton
Industry
Employees
11-50
Founded
2018
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President , Clinical Operations and Program Management
Email ****** @****.comPhone (***) ****-****Vice President Regulatory Affairs
Email ****** @****.comPhone (***) ****-****Non Executive Director
Email ****** @****.comPhone (***) ****-****Independent Board Director
Email ****** @****.comPhone (***) ****-****
Technologies
(49)
Reach decision makers at PepGen
Free credits every month!
PepGen FAQ
Newton, United States
Biotechnology Research
